Korea Arlico Pharm Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include chlorhexidine, smol, mudis, emmao plus, and acrason cream, eldosin capsule, arlicough, conazine, and mosarin tabs, and others. The company was founded December 28, 1992 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company